STAT Plus: Pharmalittle: FDA to issue guidance on Covid-19 vaccines; what remesdivir pricing may really mean
Top of the morning to you, and a fine one it is. A shiny sun…
Category: Pharma
STAT Plus: Gilead’s pricing for remdesivir raises questions about the drug’s long-term prospects
After weeks of anticipation, Gilead Sciences (GILD) finally disclosed the pricing for its remdesivir experimental…
STAT Plus: Pharma trade group scolds AstraZeneca for bad behavior over an advisory board
A U.K. pharmaceutical industry trade group has publicly reprimanded AstraZeneca (AZN) for failing to uphold…
STAT Plus: Pharmalittle: Pharma giants plan $1 billion antibiotic venture; Gilead prices remdesivir below most estimates
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharma giants to unveil major $1 billion venture to push novel antibiotics
Amid escalating concerns over antibiotic resistance, several big drug makers are creating a new $1…
STAT Plus: Pfizer sues Trump administration over anti-kickback rules, saying they prevent it from helping lower seniors’ drug costs
WASHINGTON — Pharmaceutical giant Pfizer is suing the Trump administration over two long-standing Medicare rules…
STAT Plus: Pharmalittle: Sanofi to cut hundreds of jobs; former BARDA chief claims Azar is sabotaging his new job
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Novartis to pay $345 million to U.S. authorities for bribing doctors in different countries
Novartis (NVS) agreed to pay more than $345 million to resolve criminal charges brought by…
STAT Plus: Pharmalittle: NIH may own patents for the Moderna Covid-19 vaccine; ICER boosts recommended price for remdesivir
Hello, everyone, and how are you this morning? Another balmy day is unfolding here on…
Hospitals see shortages of a cheap steroid that one study says helps Covid-19 patients
After preliminary release of a study found that a cheap steroid reduced deaths by a…
STAT Plus: A pill to fight alcoholism causes an uproar in France over a regulator’s view of a clinical trial
Two years ago, French regulators made a surprising decision, overruling one of their own expert…
.jpg)
STAT Plus: Federal prosecutors allege Regeneron used a charity to pay kickbacks to Medicare patients
Federal officials on Wednesday alleged that Regeneron Pharmaceuticals (REGN) donated tens of millions of dollars…
STAT Plus: Pharmalittle: WHO sets goals for distributing Covid-19 treatments; new warnings urged on diabetes drugs
Hello, everyone, and how are you today? A bright shiny sun and cool breezes are…
STAT Plus: FDA urged to heighten safety warnings on common type 2 diabetes drugs
A consumer advocacy is urging the Food and Drug Administration to heighten warnings about a…
STAT Plus: Pharmalittle: Sanofi steps up Covid-19 vaccine efforts; has a successor to FDA’s Janet Woodcock been found?
Top of the morning to you. And a steamy one, it is. In fact, there…
Lawmakers push Covid-19 bills to prevent price gouging, track federal funds used to discover drugs
Amid ongoing concern that Covid-19 therapies and vaccines may be unaffordable, a bipartisan group of…
STAT Plus: Pharmalittle: Will a Covid-19 vaccine protect the elderly? Generic remdesivir to cost up to $79 a dose
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Europe nears a deal for J&J Covid-19 vaccine; Biogen loses a big patent case
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Vertex and Canada hold talks over cystic fibrosis drug, but a deal for newer medicine remains out of reach
The icy relationship between Vertex Pharmaceuticals (VRTX) and the Canadian government is showing signs of…
STAT Plus: Clinical trial costs to develop a new drug may actually be rather modest — or so one study suggests
For years, the pharmaceutical industry has maintained that the costs to develop medicines accounts for…
STAT Plus: Pharmalittle: Trump pushes for Covid-19 vaccine by year’s end; Americans fear pharma will keep raising drug prices
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
.jpg)
STAT Plus: A majority of Americans fear pharma will use Covid-19 as an excuse to raise prices
Amid a race to find therapies and vaccines to combat Covid-19, a new poll finds…
Some Covid-19 trial sponsors never posted other study results in an EU database. Will they hide data again?
Amid a wave of research into potential Covid-19 therapies, a new analysis warns that some…
STAT Plus: California attorney general says FTC failed to follow ‘best practices’ in approving AbbVie-Allergan deal
Arguing that the Federal Trade Commission did not follow “best practices” in approving AbbVie’s recent…
STAT Plus: Pharmalittle: White House says Covid-19 vaccine will be free to the ‘vulnerable’; vaccine makers hunt for glass vials
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: As quality concerns rise, FDA report shows Indian drug plants inspected more often — and had more problems
As concerns mount over the quality of the pharmaceutical supply chain, the Food and Drug…
STAT Plus: Royalty Pharma, a drug company that doesn’t develop drugs, shatters IPO record
Royalty Pharma, a business built on investing in other people’s medicines, raised $2.2 billion in…
STAT Plus: Pharmalittle: Cheap steroid reduced deaths in severe Covid-19 patients; what the FDA decision on hydroxychloroquine means
Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like…
STAT Plus: A YouTube ‘hit job’ about a Catalyst Pharma rival is posted amid its battle with the FDA
In a move that resembles a scare tactic, a newly posted YouTube video shows a…
STAT Plus: Pharmalittle: Lilly begins studying RA drug for Covid-19; AstraZeneca to provide Europe 400 million vaccine doses
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: A would-be chain of cancer centers wants to treat patients with Right to Try drugs, raising ethical questions
In an unusual move, a private equity firm is soliciting investors to help create a…
STAT Plus: Antimicrobials benefited from expedited FDA programs more than other drugs
Amid concerns over the need for more antimicrobials, a new analysis finds these medicines benefited…
STAT Plus: Pharmalittle: U.S. Chamber wants transparency around Covid-19 vaccines; EU to pump billions into vaccine deals
And so, another working week will soon draw to a close. If you are surprised…
STAT Plus: Pharmalittle: Pfizer CEO says Covid-19 vaccine price won’t be huge; Lilly antibody therapy may be ready by fall
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
STAT Plus: California supports an attorney’s unusual whistleblower lawsuit against ‘fraudulent’ patents
The California insurance commissioner is supporting an unusual gambit by a patent attorney who filed…
STAT Plus: States file a third lawsuit accusing dozens of generic drug makers of price fixing
An ongoing probe by numerous states widened with a new lawsuit accusing more than two…
STAT Plus: Pharmalittle: Fauci encourages fair pricing for Covid-19 products; U.S. plans to start pivotal vaccine trials this summer
Good morning, everyone, and how are you today? The heat continues to rise higher here…
STAT Plus: Many Canadian medical societies fail to disclose industry funding in their clinical guidelines
Many Canadian medical societies and specially focused disease groups fail to disclose industry funding in…
STAT Plus: A judge rules AbbVie isn’t ‘immunized’ from antitrust claims over its Humira patent dealings
In a victory for AbbVie (ABBV), a U.S. federal judge ruled the drug maker did…
STAT Plus: Judge rules AbbVie didn’t unfairly thwart Humira competition with its ‘patent thicket’
In a victory for AbbVie (ABBV), a U.S. federal judge ruled the drug maker did…
STAT Plus: Pharmalittle: Compounders push to make pandemic changes permanent; production concerns seen for Covid-19 monoclonals
Hello, everyone, and how are you this fine, sunny morning? Here on the Pharmalot campus,…
STAT Plus: Why would AstraZeneca want to buy Gilead? Some analysts say it’s not entirely clear
Amid intense interest in Gilead Sciences (GILD) thanks to its experimental Covid-19 drug, an out-of-left-field…
STAT Plus: The next record-setting IPO: a drug company that doesn’t develop drugs
Royalty Pharma, a business built on investing in other people’s medicines, is planning to raise…
STAT Plus: Pharmalittle: Will AstraZeneca bid for Gilead?; university terminates researcher over Covid-19 papers
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Will the ‘patent dance’ cause Amgen to temporarily pull a biosimilar off the market?
In a closely watched case, a federal appeals court must decide whether a biosimilar company…
STAT Plus: Pharmalittle: Groups backed by pharma oppose equitable Covid-19 pricing; AstraZeneca strikes big Covid-19 vaccine deal
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Wholesale drug prices — and net prices — keep falling for most drugs
Amid continued political pressure on the pharmaceutical industry, a new analysis finds that brand-name drug…
STAT Plus: Inovio sues a key contract manufacturer as it races to develop a Covid-19 vaccine
As the race to develop a Covid-19 vaccine accelerates, Inovio Pharmaceuticals (INO) filed a lawsuit…
STAT Plus: Pharmalittle: Five Covid-19 vaccine makers chosen for Warp Speed project; Moderna CEO defends data release
Good morning, folks, and how are you today? We are doing just fine, thank you….
STAT Plus: Tiny Denmark saved lots of money on biosimilar Humira, while Americans are still paying big bucks
For those yearning for the day when biosimilars save the U.S. health care system huge…